Michael Stewart replaces Rose Crane in Mela hotseat
This article was originally published in Clinica
Executive Summary
Melanoma detection specialist Mela Sciences has appointed Michael Stewart president and CEO, effective 15 December. He replaces Rose Crane, who has resigned with immediate effect. Ms Crane was appointed in November 2013, not long after previous chief Joseph Gulfo quit in June 2013 after nine years with the company. Mr Stewart, who joined Mela’s board in August, headed up Surgical Laser Technologies from 1999 until 2002, when it was acquired by medical laser specialist PhotoMedex. Since then, he has been chief operating officer and executive vice-president at PhotoMedex, where he led the domestic and international sales organizations, marketing, product development and engineering, manufacturing and service operations. Mr Stewart has resigned from PhotoMedex, effective 14 December.